Last reviewed · How we verify
NCT03405415
Assessment of Glucose Concentrations in People Without Diabetes Mellitus After Standardized Meals and in Daily Life
NA trial testing Blood glucose monitoring system and continuous interstitial glucose monitoring system in Subjects Without Diabetes Mellitus in 41 participants. Completed in 10 July 2019.
10 July 2019
Quick facts
| Lead sponsor | Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 41 |
| Start date | 27 January 2018 |
| Primary completion | 10 July 2019 |
| Estimated completion | 10 July 2019 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Blood glucose monitoring system and continuous interstitial glucose monitoring system
Conditions studied
- Subjects Without Diabetes Mellitus — all drugs for Subjects Without Diabetes Mellitus →
- Assessment of Glucose Concentrations — all drugs for Assessment of Glucose Concentrations →
Sponsor
Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm
Who can join
18 and older, any sex, with Subjects Without Diabetes Mellitus or Assessment of Glucose Concentrations. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Participants will perform blood glucose monitoring (BGM) over the course of 14 days and, in parallel, wear continuous glucose monitoring (CGM) systems. Because current CGM systems typically achieve a lower level of analytical accuracy than BGM systems, participants will perform at least 5 blood glucose (BG) measurements per day. In addition, CGM systems are used to obtain minimally-invasive high-frequency glucose measurements to fill the gaps between BG measurements.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Continuous Glucose Profiles in Healthy People With Fixed Meal Times and Under Everyday Life Conditions.
Freckmann G, Schauer S, Beltzer A, Waldenmaier D, et al · · 2024 · cited 8× · PMID 35876145 · DOI 10.1177/19322968221113341
Verify or expand the search:
- PubMed search for NCT03405415
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm trials
Trials by the same sponsor.
- NCT03737188 — Institut Fuer Diabetes-Technologie Surveillance Program · NA · completed
- NCT03085251 — Clinical System Accuracy Evaluation With OneTouch® Verio Flex Blood Glucose Monitoring System (BGMS) · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03405415 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm
- Last refreshed: 28 July 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03405415.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing